KYNTRA BIO, INC. (KYNB) Return on equity 2016–2021
KYNTRA BIO, INC. (KYNB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-138.7%FY2021 · since FY2016: -37.3% → -138.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -138.7% | -93.8 pp |
| FY2020 | -44.8% | -29.9 pp |
| FY2019 | -14.9% | +2.1 pp |
| FY2018 | -17.0% | +5.9 pp |
| FY2017 | -22.9% | +14.4 pp |
| FY2016 | -37.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice